Anti-CEA Anti-HSG Bispecific Monoclonal Antibody TF2

Cancer Terms -> Drugs and Chemicals -> Pharmacologic Substance -> Biological Agent -> Monoclonal Antibody -> Anti-CEA Anti-HSG Bispecific Monoclonal Antibody TF2

Anti-CEA Anti-HSG Bispecific Monoclonal Antibody TF2 Definition

A tri-Fab bispecific monoclonal antibody (BiMoAb) divalent for the carcinoembryonic antigen (CEA) and monovalent for histamine-succinyl-glycine (HSG) peptide-hapten. Anti-CEA/anti-HSG bispecific monoclonal antibody TF2 binds to the tumor associated antigen (TAA) CEA on CEA-expressing tumor cells. Subsequently, an HSG peptide-hapten carrying a radionuclide is administered, binding to the anti-HSG binding fragment on the BiMoAb. Depending on the characteristics of the radionuclide used, CEA-expressing tumor cells may then be radioimaged and/or treated radioimmunotherapeutically.

Anti-CEA Anti-HSG Bispecific Monoclonal Antibody TF2 Synonyms

Anti-CEA/Anti-HSG Bispecific Monoclonal Antibody TF2, Anti-CEA x Anti-Histamine-Succinyl-Glycine Bispecific Monoclonal Antibody TF2, TF2

Terms in Anti-CEA Anti-HSG Bispecific Monoclonal Antibody TF2 category

---

Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.